RNS Number : 1070V Renalytix PLC 09 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 9 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase of 4,805 American Depositary Shares (" ADS ") by certain members of
RNS Number : 9024U Renalytix PLC 08 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 8 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of 950
RNS Number : 7546U Renalytix PLC 07 December 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022 LONDON and SALT LAKE CITY , December 7, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE : RENX), an artificial
RNS Number : 2978U Renalytix PLC 02 December 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7 LONDON and SALT LAKE CITY , December 2, 2021 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the
RNS Number : 0262T Renalytix PLC 19 November 2021 Renalytix plc ("Renalytix" or the "Company") Publication of Annual Report 2021 and Notice of 2021 Annual General Meeting LONDON and SALT LAKE CITY , November 19, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual
RNS Number : 8663R Renalytix PLC 10 November 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix Convenes Expert Panel at VA Healthcare Summit Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease NEW
RNS Number : 7276R Renalytix PLC 09 November 2021 Renalytix plc ("Renalytix" or the "Company") St. Joseph's Health and Renalytix Partner to Advance Value-Based Kidney Health in New York Partnership expands doctor and patient access to advanced prognosis and coordinated care management of
RNS Number : 9254Q Renalytix PLC 01 November 2021 Renalytix plc (" Renalytix " or the " Company ") Issue of shares and Total Voting Rights NEW YORK , November 1, 2021 - Renalytix plc (AIM: RENX) announces that it has issued and allotted 68,224 ordinary shares of 0.25 pence each in the
RNS Number : 7882P Renalytix PLC 21 October 2021 Renalytix plc (" Renalytix " or the " Company ") Renalytix Reports Full Year Fiscal 2021 Results LONDON and SALT LAKE CITY , October 21, 2021 - Renalytix plc (NASDAQ: RNLX), (LSE : RENX) an artificial intelligence-enabled in vitro
RNS Number : 4032O Renalytix PLC 08 October 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21 LONDON and SALT LAKE CITY , October 8, 2021 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced